IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here.
Company: ServiceMaster Global Holdings, Inc.
Symbol: SERV
Price: Last trade $28.20
Trade Date: 2/6
Shares: 25 million
Underwriter(s) J.P. Morgan, Credit Suisse, Morgan Stanley, Goldman Sachs
Co Manager(s) BofA Merrill Lynch, Jefferies, Natixis, RBC Capital Markets, Baird, Piper Jaffray, Ramirez
Rating=Subscription Needed
Company: Omega Healthcare
Symbol: OHI
Price: Last trade $43.61
Trade Date: 2/4
Shares: 8 million
Underwriter(s) BofA Merrill Lynch, J.P. Morgan, Morgan Stanley, Stifel
Rating=Subscription Needed
Company: Tonix Pharmaceuticals
Symbol: TNXP
Price: Last trade $6.06
Trade Date: 2/4
Shares: 4.1 million
Underwriter(s) Roth Capital Partners, Oppenheimer & Co.
Co Manager(s) Janney Montgomery Scott
Rating=Subscription Needed
Company: Intercept Pharmaceuticals, Inc.
Symbol: ICPT
Price: Last trade $189.07
Trade Date: 2/5
Shares: 800,000
Underwriter(s) Citigroup, RBC Capital Markets
Rating=Subscription Needed
Company: Senior Housing Properties Trust
Symbol: SNH
Price: Last trade $23.30
Trade Date: 2/4
Shares: 25 million
Underwriter(s) Citigroup, BofA Merrill Lynch, Morgan Stanley, Jefferies, RBC Capital Markets
Rating=Subscription Needed
Company: Catalyst Pharmaceutical Partners Inc.
Symbol: CPRX
Price: Last trade $3.52
Trade Date: 2/4
Shares: 8.5 million
Underwriter(s) Piper Jaffray
Rating=Subscription Needed
Company: Ultragenyx Pharmaceutical Inc.
Symbol: RARE
Price: Last trade $57.58
Trade Date: 2/5
Shares: 2.2 million
Underwriter(s) Morgan Stanley, Cowen, Jefferies
Co Manager(s) Baird, Canaccord Genuity, JMP Securities, SunTrust Robinson Humphrey, Wedbush PacGrow Life Sciences
Rating=Subscription Needed